Summary of induced net costs per annum associated with the HiNH program. by Lijun Fan (2007628)

Subjects:

Association between PMI and annual risk of mortality among children <5 years in sub-Saharan Africa. by Aleksandra Jakubowski (4107814)

Subjects:

Time trends in development assistance for malaria and coverage of malaria interventions in sub-Saharan Africa. by Aleksandra Jakubowski (4107814)

Subjects:

Description of study sample. by Aleksandra Jakubowski (4107814)

Subjects:

The US President’s Malaria Initiative and under-5 child mortality in sub-Saharan Africa: A difference-in-differences analysis by Aleksandra Jakubowski (4107814)

Subjects:

Population coverage of insecticide treated nets (ITNs), artemisinin-based combination therapy (ACTs), and indoor residual spraying (IRS) in 19 PMI-recipient countries compared to 1... by Aleksandra Jakubowski (4107814)

Subjects:

Percent difference in expected and observed incidence of acute encephalitis syndrome following Japanese encephalitis vaccination campaign, by district, Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Acute encephalitis syndrome expected and observed cases and incidence rates (IR) per 100,000 person years in Nepal. by Shyam Raj Upreti (4451614)

Subjects:

HIV prevalence among populations of men who have sex with men and transgender women in Cambodia, 1999–2019. by Jan W. de Lind van Wijngaarden (5488949)

Subjects:

PRISMA flow diagram of identified, screened, eligible and included publications. by Jan W. de Lind van Wijngaarden (5488949)

Subjects:

Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years in Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years by age group in Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Percent difference in expected and observed incidence of Japanese encephalitis following vaccination campaign, by district, Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Characteristics of confirmed invasive pneumococcal disease cases reported in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

Subjects:

Incidence rates (per 100,000 population) of invasive pneumococcal disease, by year, associated vaccine type^a and age group, in Ontario, Canada, 2007-2017^b. by Shinthuja Wijayasri (8124539)

Subjects:

Incidence rates (per 100,000 population) of invasive pneumococcal disease, by age group and year, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

Subjects:

Serotype distribution of invasive pneumococcal disease cases^a, by associated vaccine type, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

Subjects:

Number of confirmed invasive pneumococcal disease cases, by associated vaccine type^a and year, in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

Subjects:

Incidence rates (per 100,000 population) of commonly^a reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017. by Shinthuja Wijayasri (8124539)

Subjects:

VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

Subjects: